18037, Coplay, Pennsylvania Lung Cancer Score Provider Score

The Provider Score for the Lung Cancer Score in 18037, Coplay, Pennsylvania is 93 when comparing 34,000 ZIP Codes in the United States.

An estimate of 98.39 percent of the residents in 18037 has some form of health insurance. 40.59 percent of the residents have some type of public health insurance like Medicare, Medicaid, Veterans Affairs (VA), or TRICARE. About 72.39 percent of the residents have private health insurance, either through their employer or direct purchase. Military veterans should know that percent of the residents in the ZIP Code of 18037 have VA health insurance. Also, percent of the residents receive TRICARE.

For the 1,605 residents under the age of 18, there is an estimate of 30 pediatricians in a 20-mile radius of 18037. An estimate of 89 geriatricians or physicians who focus on the elderly who can serve the 1,293 residents over the age of 65 years.

In a 20-mile radius, there are 28,944 health care providers accessible to residents in 18037, Coplay, Pennsylvania.

**Lung Cancer Score Analysis: Coplay, PA (ZIP Code 18037)**

This analysis provides a comprehensive assessment of lung cancer-related healthcare resources and accessibility within Coplay, Pennsylvania (ZIP code 18037). The evaluation focuses on primary care physician availability, the quality of care, and the integration of supportive services, including mental health, to determine a "Lung Cancer Score" that reflects the community's preparedness to address this serious illness.

The foundation of effective lung cancer care rests on the availability and accessibility of primary care physicians (PCPs). In Coplay, the physician-to-patient ratio is a crucial factor. A higher ratio of patients per PCP can lead to longer wait times for appointments, potentially delaying crucial early detection and diagnosis. This analysis seeks to determine the current ratio within the defined geographic area, considering factors like the number of practicing PCPs, the population size, and the presence of any underserved populations. The availability of PCPs, especially those accepting new patients, directly impacts the community's ability to access timely screenings, such as low-dose computed tomography (LDCT) scans, which are vital for early detection of lung cancer.

Beyond simple physician numbers, the quality of primary care is paramount. This involves assessing the practices' adherence to evidence-based guidelines for lung cancer screening and prevention. This includes the implementation of smoking cessation programs, which are critical for reducing lung cancer risk. The analysis will evaluate the presence and effectiveness of these programs within Coplay's primary care practices. Furthermore, the assessment will consider the integration of electronic health records (EHRs) and their impact on care coordination, including the seamless transfer of patient information between PCPs, pulmonologists, and oncologists.

Standout practices within the Coplay area will be identified. These practices will be recognized for their commitment to excellence in lung cancer care, possibly based on their patient outcomes, patient satisfaction scores, and the utilization of advanced diagnostic and treatment modalities. The evaluation will also consider the practices' responsiveness to patient needs, including their ability to accommodate urgent appointments and provide clear and concise communication.

Telemedicine adoption is another key component of this analysis. The implementation of telehealth services has the potential to improve access to care, especially for patients in rural or underserved areas. The analysis will determine the extent to which Coplay's primary care practices utilize telemedicine for consultations, follow-up appointments, and patient education. The availability of telehealth services can be particularly beneficial for patients undergoing lung cancer treatment, allowing them to receive care from the comfort of their homes and reducing the burden of travel.

Mental health resources are often overlooked, but they are an essential element of comprehensive lung cancer care. A diagnosis of lung cancer can have a significant impact on a patient's emotional and psychological well-being. This analysis will assess the availability of mental health services within Coplay, including access to therapists, counselors, and support groups. The integration of mental health services into primary care practices is particularly important, as it allows for early identification and intervention for patients experiencing symptoms of anxiety, depression, or other mental health challenges. The analysis will consider the availability of resources for both patients and their families.

The Lung Cancer Score will be a composite measure reflecting the availability, quality, and accessibility of lung cancer-related healthcare resources in Coplay. It will be based on a weighted scoring system that considers the physician-to-patient ratio, the adherence to evidence-based guidelines, the adoption of telemedicine, and the availability of mental health resources. The score will provide a clear and concise assessment of the community's preparedness to address lung cancer.

The analysis will also consider the presence of any disparities in access to care based on socioeconomic status, race, or ethnicity. Addressing these disparities is crucial for ensuring that all residents of Coplay have equal opportunities to receive high-quality lung cancer care. The analysis will identify any barriers to care and recommend strategies for improving access for underserved populations.

The final Lung Cancer Score will be accompanied by specific recommendations for improving lung cancer care in Coplay. These recommendations may include increasing the number of PCPs, expanding the availability of telemedicine services, promoting the integration of mental health services, and implementing targeted interventions to address disparities in access to care.

The data used in this analysis will be obtained from a variety of sources, including public health data, physician directories, and practice websites. The analysis will be conducted using a rigorous methodology to ensure the accuracy and reliability of the findings. The goal is to provide a comprehensive and objective assessment of lung cancer care in Coplay.

The analysis will also consider the presence of any specialized lung cancer treatment centers or hospitals within a reasonable distance of Coplay. The availability of these resources can significantly impact patient outcomes. The analysis will evaluate the quality of care provided at these centers, including their use of advanced diagnostic and treatment modalities.

The analysis will also take into account the presence of community-based resources, such as support groups and educational programs. These resources can provide valuable support to patients and their families. The analysis will evaluate the accessibility and effectiveness of these resources.

The ultimate goal of this Lung Cancer Score analysis is to provide valuable insights into the state of lung cancer care in Coplay, Pennsylvania. By identifying strengths and weaknesses, the analysis aims to inform stakeholders, including healthcare providers, policymakers, and community members, and guide efforts to improve the quality and accessibility of care for individuals affected by this devastating disease. This comprehensive assessment will provide a foundation for data-driven improvements in the community's approach to lung cancer prevention, diagnosis, and treatment.

To visualize the data and access interactive maps detailing physician locations, practice specializations, and resource availability in Coplay and surrounding areas, we encourage you to explore the powerful mapping capabilities of CartoChrome.